Definitions of Metabolic Syndrome: Where are We Now?

E-ISSN： 1875-6212|4|3|185-197

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.4, Iss.3, 2006-07, pp. : 185-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targets for immunomodulation in cardiovascular disease – where are we now?

By Wainwright Cherry L

Future Cardiology, Vol. 1, Iss. 2, 2005-03 ,pp. : 177-189

Future Medicine

Access to resources Recommend Favorite

Microbicides: where are we now and what next?

By McCormack Sheena

HIV Therapy, Vol. 4, Iss. 6, 2010-11 ,pp. : 615-618

Future Medicine

Access to resources Recommend Favorite

Mucosal HIV Vaccines: Where are We Now?

Current HIV Research, Vol. 2, Iss. 1, 2004-01 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of Intracoronary Abciximab in Percutaneous Coronary Interventions- where are we now and where do we go from here?

Recent Patents on Cardiovascular Drug Discovery, Vol. 8, Iss. 3, 2013-12 ,pp. : 192-196

Bentham Science Publishers

Access to resources Recommend Favorite

Joint ESC/EASD Guidelines on Diabetes, where are we Now and where should we Go?

Current Vascular Pharmacology, Vol. 10, Iss. 6, 2012-11 ,pp. : 690-692

Bentham Science Publishers

Access to resources Recommend Favorite